CLINICAL_TRIALS
research
· 2026-02-09
Clinical Trial Update: Fractional Exhaled Nitric Oxide and Exacerbations of COPD
Summary
A ClinicalTrials.gov entry describes a study evaluating fractional exhaled nitric oxide as a biomarker related to exacerbations in chronic obstructive pulmonary…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Chang Gung Memorial Hospital | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Status: NOT_YET_RECRUITING